Literature DB >> 14752838

Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease.

Stephen F Stewart1, Matteo Vidali, Christopher P Day, Emanuele Albano, David E J Jones.   

Abstract

Serum antibodies reactive with neo-antigens generated during ethanol metabolism have been identified in patients with alcoholic liver disease (ALD), although their role in the pathogenesis of disease remains unclear. In this study, we characterized peripheral blood mononuclear cell (PBMC) T-cell and antibody responses to human serum albumin (HAS) adducted with acetaldehyde under reducing conditions (AcA-HSA) or with malondialdehyde (MDA-HSA) in patients with advanced ALD (AALD, n = 28), heavy drinkers with no liver disease (NALD, n = 14), and mild/moderate drinking controls (n = 22). Peak proliferative responses of PBMC were assessed in vitro by tritiated thymidine incorporation after the addition of optimized concentrations of antigen or OKT3. Antibody titers were determined by enzyme-linked immunosorbent assay (ELISA). MDA-HSA induced PBMC T-cell proliferation was significantly higher in ALD than in NALD or control patients. Moreover, 10 of 28 (36%) of ALD patients had significant T-cell proliferative responses to MDA-HSA compared to 0 of 14 (0%, P =.02) of the NALD group and 2 of 22 (9%, P <.05) of controls. No significant difference in PBMC T-cell response to Aca-HSA was seen between subject groups. Patients with positive cellular responses to MDA had higher serum anti-MDA antibody titers than those not exhibiting a positive cellular response (P <.005). In conclusion, the pattern of cellular and humoral responses to MDA adducts suggests that the development of these responses may be a susceptibility factor for the development of advanced alcoholic liver disease. The apparent importance of T-cell responses to MDA adducts suggests that oxidative stress may represent an important stimulus for the development of cellular immune responses associated with advanced ALD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752838     DOI: 10.1002/hep.20021

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

Review 1.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

2.  Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Dean J Tuma; Stanley J Radio; Carlos D Hunter; Courtney S Schaffert; Lynell W Klassen
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 3.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

4.  Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition.

Authors:  Martin J J Ronis; Angelica Butura; Brante P Sampey; Kartik Shankar; Ronald L Prior; Sohelia Korourian; Emanuele Albano; Magnus Ingelman-Sundberg; Dennis R Petersen; Thomas M Badger
Journal:  Free Radic Biol Med       Date:  2005-09-01       Impact factor: 7.376

5.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.

Authors:  E Albano; E Mottaran; M Vidali; E Reale; S Saksena; G Occhino; A D Burt; C P Day
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

6.  Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme.

Authors:  Dimitrios Stagos; Ying Chen; Chad Brocker; Elizabeth Donald; Brian C Jackson; David J Orlicky; David C Thompson; Vasilis Vasiliou
Journal:  Drug Metab Dispos       Date:  2010-07-08       Impact factor: 3.922

Review 7.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

8.  Protective effect of phosphatidylcholine on restoration of ethanol-injured hepatocytes related with caveolin-1.

Authors:  Yuan Zhang; Wei Zou; Fenggong Cui; Nan Wang; Dongyan Zhang; Yuying Cui; Peng Liu; Jing Liu
Journal:  J Membr Biol       Date:  2013-11-29       Impact factor: 1.843

9.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease.

Authors:  Xiaohua Yan; Liyun Xu; Jianni Qi; Xiaohong Liang; Chunhong Ma; Chun Guo; Lining Zhang; Wensheng Sun; Jiyun Zhang; Xiaoyi Wei; Lifen Gao
Journal:  Immunogenetics       Date:  2009-07-23       Impact factor: 2.846

10.  Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up.

Authors:  Chris Elliott; James Frith; Christopher P Day; David E J Jones; Julia L Newton
Journal:  Dig Dis Sci       Date:  2013-04-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.